{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:24:06Z","timestamp":1793431446879,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["-0609326"],"award-info":[{"award-number":["-0609326"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL007974"],"award-info":[{"award-number":["T32HL007974"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["-066738"],"award-info":[{"award-number":["-066738"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["-070343"],"award-info":[{"award-number":["-070343"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.03.034","type":"journal-article","created":{"date-parts":[[2009,4,5]],"date-time":"2009-04-05T03:34:36Z","timestamp":1238902476000},"page":"3013-3021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":261,"title":["Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy"],"prefix":"10.1016","volume":"27","author":[{"given":"Stacey L.","family":"Demento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Eisenbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald G.","family":"Foellmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Mark Saltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Mellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Ledizet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Fikrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Flavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M.","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"June (7198)","key":"10.1016\/j.vaccine.2009.03.034_bib1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.03.034_bib2","first-page":"17","article-title":"Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.03.034_bib3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.03.034_bib4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1016104910582","article-title":"Recent advances in vaccine adjuvants","volume":"19","author":"Singh","year":"2002","journal-title":"Pharm Res"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.03.034_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1176","article-title":"Recent advances in the discovery and delivery of vaccine adjuvants","volume":"2","author":"O\u2019Hagan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2009.03.034_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.addr.2004.09.003","article-title":"Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens","volume":"57","author":"Jiang","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"June (19)","key":"10.1016\/j.vaccine.2009.03.034_bib7","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.vaccine.2003.11.071","article-title":"European union regulatory developments for new vaccine adjuvants and delivery systems","volume":"22","author":"Sesardic","year":"2004","journal-title":"Vaccine"},{"issue":"April (4 Suppl.)","key":"10.1016\/j.vaccine.2009.03.034_bib8","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved vaccine adjuvants","volume":"11","author":"Pashine","year":"2005","journal-title":"Nat Med"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2009.03.034_bib9","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S1359-6446(05)03600-7","article-title":"The rational design of vaccines","volume":"10","author":"Bramwell","year":"2005","journal-title":"Drug Discov Today"},{"issue":"January (5195)","key":"10.1016\/j.vaccine.2009.03.034_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.7809629","article-title":"A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules","volume":"267","author":"Kovacsovics-Bankowski","year":"1995","journal-title":"Science"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2009.03.034_bib11","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4049\/jimmunol.158.6.2723","article-title":"Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules","volume":"158","author":"Shen","year":"1997","journal-title":"J Immunol"},{"issue":"August\u2013September (12\u201313)","key":"10.1016\/j.vaccine.2009.03.034_bib12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0264-410X(97)00047-9","article-title":"Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres","volume":"15","author":"Men","year":"1997","journal-title":"Vaccine"},{"issue":"July (30)","key":"10.1016\/j.vaccine.2009.03.034_bib13","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1016\/S0264-410X(01)00179-7","article-title":"Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants","volume":"19","author":"Peter","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.03.034_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4615-1823-5_8","article-title":"Adjuvant properties of aluminum and calcium compounds","volume":"6","author":"Gupta","year":"1995","journal-title":"Pharm Biotechnol"},{"issue":"September (27\u201328)","key":"10.1016\/j.vaccine.2009.03.034_bib15","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants\u2014in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2009.03.034_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1189\/jlb.1206755","article-title":"The inflammasome in pathogen recognition and inflammation","volume":"82","author":"Sutterwala","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"June (30)","key":"10.1016\/j.vaccine.2009.03.034_bib17","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.vaccine.2005.03.006","article-title":"A recombinant envelope protein vaccine against West Nile virus","volume":"23","author":"Ledizet","year":"2005","journal-title":"Vaccine"},{"issue":"October (28)","key":"10.1016\/j.vaccine.2009.03.034_bib18","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/j.biomaterials.2005.02.025","article-title":"Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting","volume":"26","author":"Fahmy","year":"2005","journal-title":"Biomaterials"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.03.034_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.0.CO;2-S","article-title":"Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures","volume":"28","author":"Talmor","year":"1998","journal-title":"Eur J Immunol"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2009.03.034_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(02)00461-3","article-title":"Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid","volume":"88","author":"Wiwattanapatapee","year":"2003","journal-title":"J Control Release"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2009.03.034_bib21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jbm.10019","article-title":"Uptake of poly(d,l-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo","volume":"60","author":"Newman","year":"2002","journal-title":"J Biomed Mater Res"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.03.034_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/js970047r","article-title":"Drug microencapsulation by PLA\/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations","volume":"87","author":"Thomasin","year":"1998","journal-title":"J Pharm Sci"},{"issue":"May (5673)","key":"10.1016\/j.vaccine.2009.03.034_bib23","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1126\/science.1096158","article-title":"Regulation of phagosome maturation by signals from toll-like receptors","volume":"304","author":"Blander","year":"2004","journal-title":"Science"},{"issue":"May (5876)","key":"10.1016\/j.vaccine.2009.03.034_bib24","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2009.03.034_bib25","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1021\/bm0503221","article-title":"Synthesis of protein-loaded hydrogel particles in an aqueous two-phase system for coincident antigen and CpG oligonucleotide delivery to antigen-presenting cells","volume":"6","author":"Jain","year":"2005","journal-title":"Biomacromolecules"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.03.034_bib26","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00262-006-0276-x","article-title":"Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN","volume":"56","author":"de Jong","year":"2007","journal-title":"Cancer Immunol Immunother"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2009.03.034_bib27","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1067\/mob.2001.117658","article-title":"Biodegradable microspheres containing group B Streptococcus vaccine: immune response in mice","volume":"185","author":"Hunter","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2009.03.034_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jconrel.2005.10.010","article-title":"Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency","volume":"110","author":"Kazzaz","year":"2006","journal-title":"J Control Release"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2009.03.034_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2006.12.002","article-title":"Innate immune sensing of pathogens and danger signals by cell surface toll-like receptors","volume":"19","author":"Miyake","year":"2007","journal-title":"Semin Immunol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.03.034_bib30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1189\/jlb.0305172","article-title":"The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells","volume":"78","author":"Thompson","year":"2005","journal-title":"J Leukoc Biol"},{"issue":"March (11\u201312)","key":"10.1016\/j.vaccine.2009.03.034_bib31","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.vaccine.2003.10.019","article-title":"Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A","volume":"22","author":"Tiberio","year":"2004","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.03.034_bib32","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1128\/iai.65.8.3239-3247.1997","article-title":"Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages","volume":"65","author":"Salkowski","year":"1997","journal-title":"Infect Immun"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2009.03.034_bib33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7883\/yoken.JJID.2004.150","article-title":"Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia","volume":"57","author":"Chhibber","year":"2004","journal-title":"Jpn J Infect Dis"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.03.034_bib34","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1128\/iai.60.9.3897-3903.1992","article-title":"Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes","volume":"60","author":"Petrov","year":"1992","journal-title":"Infect Immun"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.03.034_bib35","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/eji.200737192","article-title":"Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis","volume":"37","author":"Purtha","year":"2007","journal-title":"Eur J Immunol"},{"issue":"August (15)","key":"10.1016\/j.vaccine.2009.03.034_bib36","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"Shrestha","year":"2004","journal-title":"J Virol"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2009.03.034_bib37","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1128\/JVI.01650-06","article-title":"CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system","volume":"80","author":"Sitati","year":"2006","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09004393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09004393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:12:47Z","timestamp":1777536767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09004393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":37,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09004393"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}